| Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy S Iyer, S Zhang, S Yucel, H Horn, SG Smith, F Reinhardt, E Hoefsmit, ... Cancer Discovery 11 (2), 384-407, 2021 | 78 | 2021 |
| Demographic history and biologically relevant genetic variation of Native Mexicans inferred from whole-genome sequencing S Romero-Hidalgo, A Ochoa-Leyva, A Garcíarrubio, V Acuña-Alonzo, ... Nature communications 8 (1), 1005, 2017 | 62 | 2017 |
| Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1-Deficient Cells A Färkkilä, A Rodríguez, J Oikkonen, DC Gulhan, H Nguyen, ... Cancer research 81 (10), 2774-2787, 2021 | 22 | 2021 |
| Marine Archaeon Methanosarcina acetivorans Enhances Polyphosphate Metabolism Under Persistent Cadmium Stress R Jasso-Chávez, E Lira-Silva, K González-Sánchez, V Larios-Serrato, ... Frontiers in microbiology 10, 2432, 2019 | 16 | 2019 |
| Whole genome variation in 27 Mexican indigenous populations, demographic and biomedical insights I Aguilar-Ordoñez*, F Pérez-Villatoro*, H García-Ortiz, F Barajas-Olmos, ... PLoS One 16 (4), e0249773, 2021 | 15 | 2021 |
| Genomic study of dilated cardiomyopathy in a group of Mexican patients using site‐directed next generation sequencing A Carnevale, S Rosas‐Madrigal, R Rosendo‐Gutiérrez, E López‐Mora, ... Molecular Genetics & Genomic Medicine 8 (11), e1504, 2020 | 15 | 2020 |
| Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer F Perez-Villatoro, J Oikkonen, J Casado, A Chernenko, DC Gulhan, ... npj precision oncology 6 (1), 96, 2022 | 11 | 2022 |
| Delivery mode-associated gut microbiota in the first 3 months of life in a country with high obesity rates: a descriptive study C Murata, P Gutiérrez-Castrellón, F Pérez-Villatoro, I García-Torres, ... Medicine 99 (40), e22442, 2020 | 11 | 2020 |
| Functional homologous recombination assay on FFPE specimens of advanced high-grade serous ovarian cancer predicts clinical outcomes S Pikkusaari, M Tumiati, A Virtanen, J Oikkonen, Y Li, F Perez-Villatoro, ... Clinical Cancer Research 29 (16), 3110-3123, 2023 | 7 | 2023 |
| Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in FANCG P Reyes, B García-de Teresa, U Juárez, F Pérez-Villatoro, ... International Journal of Molecular Sciences 23 (4), 2334, 2022 | 6 | 2022 |
| Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer IMP Launonen, EP Erkan, I Niemiec, A Junquera, M Hincapie-Otero, ... bioRxiv, 2024.03. 19.585657, 2024 | 2 | 2024 |
| Optimized detection of allelic imbalances specific for homologous recombination deficiency improves the prediction of clinical outcomes in cancer F Perez-Villatoro, J Oikkonen, J Casado, A Chernenko, DC Gulhan, ... bioRxiv, 2021.08. 19.456809, 2021 | 2 | 2021 |
| Tribus: Semi-automated discovery of cell identities and phenotypes from multiplexed imaging and proteomic data Z Kang, A Szabo, T Farago, F Perez-Villatoro, IM Launonen, E Anttila, ... bioRxiv, 2024.03. 13.584767, 2024 | 1 | 2024 |
| Abstract B073: A spatially resolved single-cell tumor microenvironment of clinicomolecular subtypes of high-grade serous ovarian cancer F Perez-Villatoro, L van Wagensveld, A Shabanova, S Hajizadeh, ... Cancer Research 84 (5_Supplement_2), B073-B073, 2024 | | 2024 |
| A spatially resolved single-cell tumor microenvironment of clinicomolecular subtypes of high-grade serous ovarian cancer F Perez-Villatoro, L van Wagensveld, A Shabanova, S Hajizadeh, ... CANCER RESEARCH 84 (5), 2024 | | 2024 |
| Tracing back primed resistance in cancer via sister cells J Dai, S Zheng, MM Falco, J Bao, J Eriksson, S Pikkusaari, S Forstén, ... Nature Communications 15 (1), 1158, 2024 | | 2024 |
| Uusi työkalu räätälöityyn munasarjasyövän hoitoon S Pikkusaari, M Tumiati, A Virtanen, J Oikkonen, Y Li, F Perez-Villatoro, ... Duodecim 139 (9), 760, 2023 | | 2023 |
| 2022-RA-961-ESGO Real-world prospective characterization of homologous recombination deficiency in advanced ovarian cancer M Salko, F Perez-Villatoro, J Aldahdooh, A Chernenko, E Pietilä, ... International Journal of Gynecologic Cancer 32 (Suppl 2), 2022 | | 2022 |
| AI-optimized genomic homologous recombination deficiency test (HRDScar) to predict platinum and PARP inhibitor responses in high-grade serous ovarian cancer F Perez-Villatoro, J Oikkonen, M Tumiati, J Casado, S Hietanen, ... Cancer Research 81 (13_Supplement), 2059-2059, 2021 | | 2021 |
